Skip to main content

Farnum Rhonda

SVP, Comm &Medical Affairs | SVP, Comm &Medical Affairs

1 company

Insider Signal Score

51
Average
Trades Analyzed
14
12M Win Rate
33.3%
Avg 3M Return
-0.9%
Avg 12M Return
-24.9%

Farnum Rhonda is a SVP, Comm &Medical Affairs at Theravance Biopharma, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.

Estimated insider holdings value: $4.1M based on current market prices.

Holdings by Company

TBPHJun 15, 2026
Current Shares242.4K
Value$4.10M
Net Activity-108,047
Bought: 0Sold: 108.0K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Jun 15, 2026
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell13,314$16.39$218,167.20-1.8%--
Dec 3, 2025
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell31,067$18.75$582,500.81-3.4%-26.1%-
Jul 14, 2025
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell10,000$11.39$113,869.51-1.0%+21.4%+47.6%
Jun 2, 2025
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell24,000$11.00$264,000.00-6.6%+24.1%+44.0%
Apr 21, 2025
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell4,000$9.00$36,000.00-1.1%+24.3%-
Jan 21, 2025
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell4,000$9.00$36,000.00-1.3%-0.2%+122.6%
Nov 11, 2024
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell4,000$9.00$36,000.00-1.2%+0.4%+103.7%
Jul 10, 2024
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell4,000$9.00$36,000.00-1.2%-10.1%+29.9%
Feb 22, 2024
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell1,254$8.71$10,922.34-0.4%+3.5%+7.4%
Nov 21, 2023
TBPH
Theravance Biopharma, Inc.
SVP, Comm &Medical AffairsSell1,378$10.29$14,179.62-0.4%-13.2%-3.0%
Page 1Next →